Olympus Corporation to Acquire Quest Photonic Devices B.V.
Olympus Corporation announced that it has entered into an agreement to acquire Quest Photonic Devices B.V. for up to EUR50 million including milestone payments to strengthen its surgical endoscopy capabilities.
Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
The transaction consists of an upfront cash payment of $925 million, and up to an additional $300 million in a potential commercial milestone payment.
Philips Signs An Agreement to Acquire Capsule Technologies, Inc
“Integrated patient care management solutions supported by essential real-time patient data and AI are core to our strategy to improve patient outcomes and care provider productivity by seamlessly connecting care,” said Roy Jakobs, Chief Business Leader Connected Care at Royal Philips.
Thermo Fisher Scientific Completes Acquisition of Viral Vector Manufacturing Business from Novasep for Approximately €725 Mil in Cash
The company notes that Novasep's viral vector manufacturing business provides contract manufacturing services for vaccines and therapies to biotechnology companies and large biopharma customers.
Mavens Is Acquired by Komodo Health
“This acquisition disrupts the status quo, unlocking a fundamentally different opportunity for life sciences companies to gain access to differentiated insights through technology,” said Arif Nathoo, MD, CEO and co-founder of Komodo Health.
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
January 8,2021
Celularity Inc. is a clinical-stage biotechnology company, and leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived from the postpartum human placenta, and GX Acquisition Corp. (Nasdaq: GXGX), a special...
Merck Acquires AmpTec – Adds to Merck’s Lipid Manufacturing Expertise, Providing an Integrated Offering Across mRNA Value Chain
"The success of mRNA-based vaccines for Covid-19 lays the path to accelerate the development of these therapeutics for many other diseases," said Stefan Oschmann, Chairman of the Executive Board and CEO of Merck.
Bioclinica Acquires Saliency to Accelerate Digital Diagnostic Development
Bioclinica will integrate the company’s advanced AI technology into its Imaging Platform to support a growing portfolio of pharmaceutical and medical device clients.
